V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Axogen Executive Compensation (FY25)

AXGN · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): June 23, 2026
250 figures on this page: 241 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
Michael Dale, Chief Executive Officer and President, received $9,047,454 in total compensation for fiscal 2025, and Dale's total moved 2.3% higher from the $8,847,922 reported for fiscal 2024. The disclosed chief executive pay ratio for fiscal 2025 is 80:1, against median employee compensation of $112,618. For fiscal 2025, shareholders backed the say-on-pay proposal with 96.5% of votes cast for or against in favor at the meeting held June 23, 2026. Companies named in the disclosed peer group include Alphatec Holdings, Inc., AngioDynamics, Inc., Artivion, Inc., AtriCure, Inc. and Bioventus Inc., among others.
Chief executive, fiscal 2025
◇
Michael Dale
Median of the other named officers
$2,261,741
5 officers, excluding the chief executive
Latest say-on-pay support
=
June 23, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Michael Dale: $8,847,922 → $9,047,454 (2.3% higher)
CEO pay ratio: 104:1 → 80:1 (23.1% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Axogen's chief executive and what were they paid?
Michael Dale, Chief Executive Officer and President, received $9,047,454 in total compensation for fiscal 2025. Dale's total moved 2.3% higher from the $8,847,922 reported for fiscal 2024.
What was Axogen's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 96.5% of votes cast for or against in favor at the meeting held June 23, 2026.
Which companies are in Axogen's peer group?
Companies named in the disclosed peer group include Alphatec Holdings, Inc., AngioDynamics, Inc., Artivion, Inc., AtriCure, Inc. and Bioventus Inc., among others.
What is Axogen's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 80:1, against median employee compensation of $112,618.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Erick DeVinney
Chief Innovation Officer
◇—◇◇◇—◇◇
Nir Naor
Former CFO
◇———◇——◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Dale
CEO and President
◇—◇—◇—◇◇
Nir Naor
Former CFO
◇—◇—◇—◇◇
Erick DeVinney
Chief Innovation Officer
◇—◇—◇—◇◇
Marc Began
Executive Vice President and GC
◇—◇—◇—◇◇
Jens Kemp
Chief Marketing Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Dale
Chief Executive Officer and President
◇—◇—◇—◇◇
Marc Began
Executive Vice President, General Counsel and Chief Compliance Officer
◇—◇—◇—◇◇
Jens Kemp
Chief Marketing Officer
◇—◇—◇—◇◇
Erick DeVinney
Chief Innovation Officer
◇—◇—◇—◇◇
Lindsey Hartley
Chief Financial Officer
◇—◇—◇—◇◇
Nir Naor
Former Chief Financial Officer
Departed during or after this year
◇—————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Erick DeVinneyOPTION◇——◇—◇◇
Erick DeVinneyOPTION◇——◇—◇◇
Jens KempOPTION◇——◇—◇◇
Jens KempOPTION◇——◇—◇◇
Lindsey HartleyOPTION◇——◇—◇◇
Lindsey HartleyOPTION◇——◇—◇◇
Lindsey HartleyOPTION◇——◇—◇◇
Lindsey HartleyOPTION◇——◇—◇◇
Marc BeganOPTION◇——◇—◇◇
Marc BeganOPTION◇——◇—◇◇
Michael DaleOPTION◇——◇—◇◇
Michael DaleOPTION◇——◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Lindsey HartleyOption◇—◇3/16/2032
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇—
Erick DeVinneyOption◇—◇3/16/2032
RSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Jens KempRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
RSU◇◇——
PSU◇◇——
Marc BeganRSU◇◇——
RSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
Michael DaleRSU◇◇——
RSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Paul Thomas
Board chair
◇◇————◇
Amy Wendell
◇◇————◇
William Burke
◇◇————◇
John H. Johnson
◇◇————◇
Alan M. Levine
◇◇————◇
Kathy Weiler
◇◇————◇
Joseph Tyndall
◇◇————◇
Guido Neels
◇—————◇
Michael Dale served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec Holdings, Inc. ATEC
  • AngioDynamics, Inc. ANGO
  • Artivion, Inc. AORT
  • AtriCure, Inc. ATRC
  • Bioventus Inc. BVS
  • OrthoPediatrics, Corp. KIDS
  • Paragon 28, Inc. FNA
  • SI-BONE, Inc. SIBN
  • Silk Road Medical, Inc. SILK
  • STAAR Surgical Company STAA
  • Tactile Systems Technology, Inc. TCMD
  • Treace Medical Concepts, Inc. TMCI
  • Zynex, Inc. ZYXI

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 23, 2026=◇◇◇
2024June 18, 2025=◇◇◇
2023June 5, 2024=◇◇◇
2022August 15, 2023=◇◇◇
2021May 25, 2022=◇◇◇
2020May 10, 2021=◇◇◇
2019May 28, 2020=◇◇◇
2018August 14, 2019=◇◇◇
2015May 26, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Axogen files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Axogen disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Axogen sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Axogen's disclosed peer group is defensible, who names Axogen back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
250 figures on this page: 241 cited to the filing that reported them, 9 calculated from figures it prints.
241 cited to the filing
9 calculated from the filing

Documents cited

  1. 0000805928-26-000081
  2. 0000805928-26-000057
    CEO Pay Ratio · DIRECTOR COMPENSATION · Grants of Plan-Based Awards Table · Outstanding Equity Awards as of · and 1 more section
  3. 0000805928-25-000095
  4. 0000805928-25-000059
    Summary Compensation Table
  5. 0000805928-24-000079
  6. 0000805928-24-000066
    Summary Compensation Table
  7. 0000805928-23-000102
  8. 0000805928-22-000061
  9. 0000805928-21-000088
  10. 0001558370-20-007188
  11. 0001558370-19-008242
  12. 0001558370-16-006237
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Axogen executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/AXGN (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Axogen and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Axogen discloses

The companies named in AXGN's own disclosed peer group.

AngioDynamics, Inc.Artivion, Inc.AtriCure, Inc.Bioventus Inc.STAAR Surgical CompanyTactile Systems Technology, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy